GlyCulator: A Glycemic Variability Calculation Tool for Continuous Glucose Monitoring Data

Glycemic variability has become a major concern over the years as growing evidence is gathered on its detrimental impact on the risk of diabetes complications. Glycated hemoglobin, although ubiquitous in clinical practice, does not adequately summarize short-term glycemic variability. This gap may be addressed through the use of continuous glucose monitoring, which continuously estimates glycemia based on interstitial fluid glucose concentration. As the amount of collected data is substantial, variability of the glycemic pattern can be analyzed in context of its direction, periodicity, and amplitude. As freely available variability calculation tools are limited in number and complexity, the authors have devised a simple-to-use Web-based application, “GlyCulator,” allowing for rapid computation of glucose variability parameters from continuous glucose monitoring data.

[1]  Boris Kovatchev,et al.  Statistical tools to analyze continuous glucose monitor data. , 2009, Diabetes technology & therapeutics.

[2]  A. Rigby,et al.  A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes , 2008, Diabetes Care.

[3]  J M Wójcicki,et al.  Mathematical Descriptions of the Glucose Control in Diabetes Therapy. Analysis of the Schlichtkrull “M”-Value , 1995, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[4]  Howard Zisser,et al.  Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. , 2009, Diabetes technology & therapeutics.

[5]  G. Jenkins,et al.  Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[6]  David Rodbard,et al.  Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. , 2009, Diabetes technology & therapeutics.

[7]  Wójcicki Jm.  Mathematical Descriptions of the Glucose Control in Diabetes Therapy. Analysis of the Schlichtkrull “M”-Value , 1995 .

[8]  David Rodbard,et al.  New and improved methods to characterize glycemic variability using continuous glucose monitoring. , 2009, Diabetes technology & therapeutics.

[9]  R. Hovorka,et al.  Glycemic Variability Correlates Strongly With Postprandialβ-Cell Dysfunction in a Segment of Type 2 Diabetic Patients Using Oral Hypoglycemic Agents , 2009, Diabetes Care.

[10]  M. Leinung,et al.  Benefits of continuous glucose monitor use in clinical practice. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[11]  Yancheng Xu,et al.  Intermittent high glucose enhances cell proliferation and VEGF expression in retinal endothelial cells: the role of mitochondrial reactive oxygen species , 2010, Molecular and Cellular Biochemistry.

[12]  J. Hans DeVries,et al.  Glucose variability is associated with intensive care unit mortality* , 2010, Critical care medicine.

[13]  Z. Dai,et al.  Intermittent high glucose exacerbates the aberrant production of adiponectin and resistin through mitochondrial superoxide overproduction in adipocytes. , 2010, Journal of molecular endocrinology.

[14]  J. Krinsley.  Glycemic variability in critical illness and the end of Chapter 1. , 2010, Critical care medicine.

[15]  W. F. Taylor,et al.  Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability , 1970, Diabetes.

[16]  Wójcicki Jm,et al.  J"-index. A new proposition of the assessment of current glucose control in diabetic patients. , 1995 .

[17]  G. Van den Berghe,et al.  Insulin therapy in very-low-birth-weight infants. , 2009, The New England journal of medicine.

[18]  David R. Owens,et al.  Glycemic Variability: The Third Component of the Dysglycemia in Diabetes. Is it Important? How to Measure it? , 2008, Journal of diabetes science and technology.

[19]  Antonio Ceriello,et al.  The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes , 2007, Diabetes Care.

[20]  Jean-Paul Cristol,et al.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.

[21]  C. McDonnell,et al.  A novel approach to continuous glucose analysis utilizing glycemic variation. , 2005, Diabetes technology & therapeutics.

[22]  Y. Matsuyama,et al.  The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up. , 2010, Diabetes research and clinical practice.

[23]  W. F. Taylor,et al.  Day-to-day variation of continuously monitored glycaemia: A further measure of diabetic instability , 1972, Diabetologia.

[24]  T. Higuchi.  Approach to an irregular time series on the basis of the fractal theory , 1988 .

[25]  Michael Brownlee,et al.  The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes , 2007, Diabetes Care.

[26]  Peter C O'Brien,et al.  The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes , 2007, Diabetes Care.